BTD
DGX icon

BankPlus Trust Department’s Quest Diagnostics DGX Stock Holding History

BankPlus Trust Department’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Buy
12,236
+431
+4% +$84.6K 0.61% 36
2026
Q1 		$2.31M Sell
11,805
-1,398
-11% -$272K 0.62% 41
2025
Q4 		$2.29M Buy
13,203
+138
+1% +$25.1K 0.6% 39
2025
Q3 		$2.49M Buy
13,065
+776
+6% +$138K 0.67% 31
2025
Q2 		$2.21M Buy
12,289
+753
+7% +$131K 0.65% 35
2025
Q1 		$1.95M Buy
11,536
+954
+9% +$157K 0.65% 34
2024
Q4 		$1.6M Buy
+10,582
New +$1.65M 0.52% 44

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

BankPlus Trust Department's DGX Position: Q2 2026 in Review

BankPlus Trust Department increased its Quest Diagnostics (DGX) stake by 3.7% in Q2 2026, buying an estimated $84.6K and bringing the position to 12,236 shares worth $2.59M. The position accounts for 0.61% of the portfolio, ranked #36.

BankPlus Trust Department first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 1,111 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • BankPlus Trust Department held 12,236 shares of Quest Diagnostics worth $2.59M as of Q2 2026.
  • BankPlus Trust Department bought 431 Quest Diagnostics shares in Q2 2026, an estimated $84.6K.
  • Quest Diagnostics made up 0.61% of BankPlus Trust Department's portfolio in Q2 2026, its #36 holding.
  • BankPlus Trust Department first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 1,111 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on BankPlus Trust Department's 13F filing for Q2 2026, filed 28 Jul 2026.